0001628280-24-001164.txt : 20240111
0001628280-24-001164.hdr.sgml : 20240111
20240111161011
ACCESSION NUMBER: 0001628280-24-001164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240109
FILED AS OF DATE: 20240111
DATE AS OF CHANGE: 20240111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schaeffer Orlov S Nicole
CENTRAL INDEX KEY: 0001401017
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30739
FILM NUMBER: 24529357
MAIL ADDRESS:
STREET 1: INSMED INCORPORATED
STREET 2: 10 FINDERNE AVENUE
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSMED Inc
CENTRAL INDEX KEY: 0001104506
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 541972729
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 908-977-9900
MAIL ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: INSMED INC
DATE OF NAME CHANGE: 20000128
4
1
wk-form4_1705007402.xml
FORM 4
X0508
4
2024-01-09
0
0001104506
INSMED Inc
INSM
0001401017
Schaeffer Orlov S Nicole
700 US 202/206
BRIDGEWATER
NJ
08807
0
1
0
0
Chief People Strategy Officer
1
Common Stock
2024-01-09
4
M
0
503
20.49
A
105652
D
Common Stock
2024-01-09
4
S
0
503
29.56
D
105149
D
Common Stock
2024-01-09
4
S
0
3165
28.74
D
101984
D
Stock Option (right to buy)
20.49
2024-01-09
4
M
0
503
0
D
2024-01-10
Common Stock
503
0
D
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
This is the weighted average sales price representing 3,165 shares sold at prices ranging from $28.72 to $28.74 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
/s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact
2024-01-11